Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice.
Rischio and Prevenzione Investigators. Rischio and Prevenzione Investigators. Trials. 2010 May 28;11:68. doi: 10.1186/1745-6215-11-68. Trials. 2010. PMID: 20509875 Free PMC article. Clinical Trial.
Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients' risk level.
Roccatagliata D, Avanzini F, Monesi L, Caimi V, Lauri D, Longoni P, Marchioli R, Tombesi M, Tognoni G, Roncaglioni MC; Collaborative Group Risk and Prevention Study. Roccatagliata D, et al. Among authors: avanzini f. Vasc Health Risk Manag. 2006;2(4):507-14. doi: 10.2147/vhrm.2006.2.4.507. Vasc Health Risk Manag. 2006. PMID: 17323606 Free PMC article.
Overall cardiovascular risk still ignored in general practice care of hypertension.
Camisasca P, Avanzini F, Alli C, Colombo F, Tognoni G; Studio sul Trattamento Antipertensivo nella Pratica ambulatoriale (STAP) participants. Camisasca P, et al. Among authors: avanzini f. J Cardiovasc Risk. 2002 Jun;9(3):147-52. doi: 10.1177/174182670200900303. J Cardiovasc Risk. 2002. PMID: 12202837
Risks and benefits of early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: analysis of the GISSI-3 database.
Avanzini F, Ferrario G, Santoro L, Peci P, Giani P, Santoro E, Franzosi MG, Tognoni G; Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico-3 Investigators. Avanzini F, et al. Am Heart J. 2002 Dec;144(6):1018-25. doi: 10.1067/mhj.2002.126739. Am Heart J. 2002. PMID: 12486426 Clinical Trial.
150 results